Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
27 results
  • Head and Neck Cancer, Lung Cancer

19-217          N/A

A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201) (View details on clinicaltrial.gov)

  • Melanoma, Lung Cancer, Head and Neck Cancer, Bladder Cancer

18-418          Phase III

A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial. (View details on clinicaltrial.gov)

  • Head and Neck Cancer

17-018          Phase I

A Multicenter, Phase 1, Open-Label, Dose-Escalation Study of ABBV-927, an Immunotherapy, in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Head and Neck Cancer

16-337          Phase II

A Multicenter, Randomized, Double-blind Phase 2 Trial of Lenvatinib (E7080) in Subjects With 131I-Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Cellular Therapy

17-193          Phase III

A Multicentre, Randomized, Open-label, Phase III Clinical Trial of Gemcitabine and Carboplatin followed by Epstein-Barr Virusspecific Autologous Cytotoxic T Lymphocytes versus Gemcitabine and Carboplatin as First Line Treatment for Advanced Nasopharyngeal Carcinoma Patients (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Lung Cancer

17-002          Phase I

A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma

17-674          Phase I

A Phase 1, Dose Escalation Study of ALX148 in Patients With Advanced Solid Tumors and Lymphoma (View details on clinicaltrial.gov)

  • Cervical Cancer, Lung Cancer, Kidney Cancer, Head and Neck Cancer, Sarcoma

19-090          Phase I

A Phase 1, First-in-Human, Open-Label, Dose Escalation and Cohort Expansion Study of MGD019, a Bispecific DART® Protein Binding PD-1 and CTLA-4 in Patients with Unresectable or Metastatic Neoplasms (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Lung Cancer, Melanoma, Metastatic/Advanced Cancer, Bladder Cancer

17-330          Phase I

A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Melanoma, Metastatic/Advanced Cancer, Merkel Cell Carcinoma, Breast Cancer

17-334          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation Study or MRNA-2416, A Lipid Nanoparticle Encapsulated MRNA Encoding Human OX4OL, For Intratumoral Injection to Patients with Advanced Malignancies (View details on clinicaltrial.gov)

Showing 1 - 10 of 27 results